Typical GLP-1 medication criteria include BMI 30 or greater, or BMI 27 or greater with qualifying conditions
Your doctor may also track blood sugar, hormone balance, and metabolic health to confirm results.
The dark side of GLP-1 receptor agonists primarily revolves around gastrointestinal issues, such as nausea
19-25 The GLP-1 RA and insulin secretagogue/insulin doses can subsequently be titrated on the basis of individualized needs to achieve the desired level of glycemic control
It was the most effective antidiabetic agent anyone had ever seen, says Andrew Young, former vice president of research at Amylin Pharmaceuticals, the San Diegobased company that brought Byetta to market
Regardless of the form, cost and insurance coverage remain major hurdles